Why Are Peptides Labeled "For Research Use Only"?
Many people ask why some peptides are sold for research use only instead of being FDA-approved medications.
The short answer is that most research peptides have not completed the full regulatory process required for approval as drugs.
Before a medicine can receive approval from the U.S. FDA, it must go through years of laboratory research, clinical trials, and regulatory review to evaluate its safety, effectiveness, manufacturing quality, and appropriate use for specific medical conditions.
Many peptides are still being studied because researchers are investigating how they work, what potential applications they may have, and whether they meet the standards required for approval. Until that process is complete, these compounds are not approved by the FDA for treating, preventing, or diagnosing disease.
As scientific understanding continues to grow, some peptides may eventually become approved medications, while others may remain research compounds. The research-only label reflects their current regulatory status, not a judgment about future outcomes.
At Future Human, we believe informed decisions start with accurate information. That's why we're committed to sharing educational resources that explain the science and regulatory landscape surrounding peptide research.
Quality Assurance
Our Quality Commitment
Learn about our custom lot production, testing standards, and verification process.
Safety & Disclaimer
Peptide Safety Checklist
Read before you use any peptide for research to reduce avoidable risks.
Looking for a trusted research peptide source?
Reach out to check availability or ask any questions before placing an order.